From: Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?
W and W | CT | Ri-CT | RT-CT | RT | Ri | |
---|---|---|---|---|---|---|
Responses | ||||||
CR | 69.2% | 75% | 94.7% | 80.9% | 57.1% | |
PR | 19.2% | 16.7% | 5.3% | 9.5% | 42.9% | |
SD | 0 | 2.8% | 0 | 0 | 0 | |
PD | 11.6% | 5.5% | 0 | 9.5% | 0 | |
Relapse rate | - | 69.2% | 38.9% | 84.2% | 90.5% | 42.9% |
Median PFS 7,5 y | 26% | 23% | 60% | 26% | 19% | - |
Median OS 7.5y | 72% | 74% | 74% | 67% | 66% | 100% |